Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trialJohn M. Kirkwood, Jeffrey S. Weber, Michele Del Vecchio et al.|European Journal of Cancer|2025Cited by 10
Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND StudyKhaled M. Musallam, Kevin H.M. Kuo, Alì Taher et al.|Blood|2023Cited by 6